An OS For The Body? Microsoft Inks First Brain Implant Partnership

Don’t miss out on our latest stories. Add PCMag as a preferred source on Google.

Microsoft is getting into the fast-evolving brain implant space through a new partnership with Inbrain, a first of its kind for the tech giant.

The goal is to create new types of therapy for patients with neurological disorders, such as Parkinson’s disease, epilepsy, and psychiatric or memory disorders. Inbrain will apply Microsoft’s agentic AI and cloud technology to its brain-computer interface (BCI), which could facilitate faster treatment based on what’s happening in the brain at that moment.

“It’s like upgrading from a remote control to a smart assistant that understands contexts, adapts, and collaborates with you,” Inbrain CEO and co-founder Carolina Aguilar tells us. It “behaves more like an operating system for the body… continuously reads what’s happening in the brain, interprets those signals using advanced AI, predicts intent or changes in neural states, and responds with the right therapy or action in real time.”

Inbrain’s BCI differs in form and function from implants made by rivals Neuralink or Synchron. The strap-like device (pictured above) lays across the brain and is the first brain implant made out of graphene, or a single layer of carbon atoms.

“This collaboration highlights the next frontier of AI,” says Clare Barclay, Microsoft’s president of enterprise and industry. Inbrain chose Microsoft as a partner for its AI models, “secure and scalable cloud infrastructure,” and experience with regulated healthcare environments.

The first step for the partnership is to integrate Microsoft’s AI models into the implant, and see if it can decode brain waves in real time. Inbrain is also finalizing the system architecture for using the tech in a clinical setting, so it can test it on patients. The company is not yet doing clinical trials in the US, though it is in the UK, and hopes to expand stateside in 2026.

Recommended by Our Editors

“Instead of bringing people to the neurologist, we aim to bring the neurologist to the people, in real time, in a personalized way, powered by AI and scalable technology,” Aguilar says. “Microsoft’s global scale and data innovation make that vision achievable.”

Microsoft is just the latest big tech exploring brain implants, though not actually manufacturing them. Apple this year built a standard Bluetooth connection for BCIs, and Synchron became the first to offer it to patients. OpenAI CEO Sam Altman is reportedly fundraising for a brain implant startup called Merge. Nvidia has been working for several years to “digitize brain waves,” extracted through a brain implant, and apply AI to the data.

Our sources tell us most tech companies see brain implants as a long-term strategic play, and their short-term goals are mostly to set up these partnerships and see how they evolve over time. No BCIs are approved by the Food and Drug Administration (FDA), and all are in varying stages of the clinical trial process, including Neuralink.